Epidemiology of Vascular Inflammation & Atherosclerosis
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Atherosclerosis
Related studies linked through entity extraction aliases.
Framingham: Inflammation, Genes & Cardiovascular Disease
- Status
- COMPLETED
- Phase
- N/A
Gene-Specific Responses to Exercise in Discordant Twins
- Status
- COMPLETED
- Phase
- N/A
Genetic and Environmental Determinants of Triglycerides (GOLDN)
- Status
- COMPLETED
- Phase
- N/A
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
- Status
- COMPLETED
- Phase
- PHASE3
Estrogen Receptor Variants, HDL, and Atherosclerosis
- Status
- COMPLETED
- Phase
- N/A
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
- Status
- COMPLETED
- Phase
- PHASE4
Cholesterol Homeostasis in Framingham Offspring Study
- Status
- COMPLETED
- Phase
- N/A
Inflammatory Genomics in Human Carotid Artery Disease
- Status
- COMPLETED
- Phase
- N/A
Epidemiology of Coronary Heart Disease in Men Aged 40 and Over
- Status
- COMPLETED
- Phase
- N/A
ARISE - Aggressive Reduction of Inflammation Stops Events
- Status
- UNKNOWN
- Phase
- PHASE3
Ventricular Size and Value Calcification Measures by Computed Tomography - Ancillary to MESA
- Status
- COMPLETED
- Phase
- N/A
Gene-by-Smoking Interactions and Risk of Atherosclerosis - Ancillary to ARIC
- Status
- COMPLETED
- Phase
- N/A
Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA
- Status
- COMPLETED
- Phase
- N/A
Gene-Environment Interactions in Complex Disease
- Status
- COMPLETED
- Phase
- N/A
Modeling DNA Diversity in Reverse Cholesterol Transport
- Status
- COMPLETED
- Phase
- N/A
Neighborhoods and CVD Risk in a Multiethnic Cohort - Ancillary to MESA
- Status
- COMPLETED
- Phase
- N/A
Epidemiology of Carotid IMT Progression in MESA - Ancillary Study
- Status
- COMPLETED
- Phase
- N/A
Aortic Calcium: Epidemiology and Progression -- Ancillary to MESA
- Status
- COMPLETED
- Phase
- N/A
A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3